Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in Taiwan
Phase of Trial: Phase IV
Latest Information Update: 27 Mar 2018
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 31 Aug 2018 Biomarkers information updated
- 21 Mar 2018 Status changed from recruiting to completed.
- 09 Jan 2018 Planned End Date changed from 30 Dec 2017 to 28 Feb 2018.